Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent. (2021)
Attributed to:
Definition and induction of broadly protective responses against HIV-1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkaa523
PubMed Identifier: 33367767
Publication URI: http://europepmc.org/abstract/MED/33367767
Type: Journal Article/Review
Volume: 76
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 4
ISSN: 0305-7453